The Net Margin of GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) is 17.08%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | 17.08% |
| 2023-03-31 | 18.78% |
| 2022-03-31 | 51.70% |
| 2021-03-31 | 12.24% |
| 2020-03-31 | 2.89% |
| 2019-03-31 | 14.24% |
| 2018-03-31 | 12.11% |
| 2017-03-31 | 11.23% |
| 2016-03-31 | 13.25% |
| 2015-03-31 | 14.42% |